Related references
Note: Only part of the references are listed.Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes
Richard Fritz et al.
VACCINE (2012)
Tick-borne encephalitis (TBE): An underestimated risk…still
Ursula Kunze
Ticks and Tick-Borne Diseases (2012)
A Tick-borne Encephalitis Virus Vaccine Based on the European Prototype Strain Induces Broadly Reactive Cross-neutralizing Antibodies in Humans
Klaus K. Orlinger et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Human IgG Subclasses: In Vitro Neutralization of and In Vivo Protection against West Nile Virus
Yvonne Hofmeister et al.
JOURNAL OF VIROLOGY (2011)
Characterization of the RepliVax platform for replication-defective flavivirus vaccines
Alexander A. Rumyantsev et al.
VACCINE (2011)
Prevention of tick-borne encephalitis by FSME-IMMUN® vaccines: Review of a clinical development programme
Alexandra Loew-Baselli et al.
VACCINE (2011)
Tick-borne encephalitis: new paradigms in a changing vaccination environment
Ursula Kunze
WIENER MEDIZINISCHE WOCHENSCHRIFT (2011)
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
Bruno Guy et al.
VACCINE (2010)
Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates
Olga A. Maximova et al.
JOURNAL OF VIROLOGY (2008)
Identification of mutated cyclization sequences that permit efficient replication of West Nile virus genomes: Use in safer propagation of a novel vaccine candidate
Ryosuke Suzuki et al.
JOURNAL OF VIROLOGY (2008)
Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers
Peter F. Wright et al.
VACCINE (2008)
Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis
Tomohiro Ishikawa et al.
VACCINE (2008)
Tick-borne encephalitis (TBE) vaccination:: Applying the most suitable vaccination schedule
I. Schoendorf et al.
VACCINE (2007)
Production and characterization of vaccines based on flaviviruses defective in replication
Peter W. Mason et al.
VIROLOGY (2006)
A live, attenuated recombinant West Nile virus vaccine
TP Monath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice
AA Rumyantsev et al.
JOURNAL OF VIROLOGY (2006)
Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys
AA Rurayantsev et al.
VACCINE (2006)
Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus
CYH Huang et al.
JOURNAL OF VIROLOGY (2005)
ChimeriVax-West Nile virus live-attenuated vaccine: Preclinical evaluation of safety, immunogenicity, and efficacy
J Arroyo et al.
JOURNAL OF VIROLOGY (2004)
Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development
CYH Huang et al.
JOURNAL OF VIROLOGY (2003)
Clinical proof of principle for ChimeriVax™:: recombinant live, attenuated vaccines against flavivirus infections
TP Monath et al.
VACCINE (2002)
Molecular organization of a recombinant subviral particle from tick-borne encephalitis
I Ferlenghi et al.
MOLECULAR CELL (2001)
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2000)
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: Dose-response effectiveness and extended safety testing in rhesus monkeys
TP Monath et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
